Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
OMIM | RCV000018300 | SCV000038579 | risk factor | Benzene toxicity, susceptibility to | 2008-07-01 | no assertion criteria provided | literature only | |
OMIM | RCV000018301 | SCV000038580 | risk factor | Leukemia, post-chemotherapy, susceptibility to | 2008-07-01 | no assertion criteria provided | literature only | |
OMIM | RCV000018302 | SCV000038581 | pathogenic | Breast cancer, post-chemotherapy poor survival in | 2008-07-01 | no assertion criteria provided | literature only | |
Database of Curated Mutations |
RCV000434090 | SCV000505705 | not provided | Lung carcinoma | 2016-03-10 | no assertion provided | literature only | |
Prevention |
RCV003974839 | SCV004798096 | benign | NQO1-related disorder | 2019-10-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |